Literature DB >> 18787016

Association of soluble cell adhesion molecules with ankle-brachial index in a biethnic cohort of predominantly hypertensive individuals.

Mahyar Khaleghi1, Zeenat Ali, Thomas H Mosley, Stephen T Turner, Iftikhar J Kullo.   

Abstract

BACKGROUND: Higher plasma concentrations of soluble adhesion molecules have been shown to be associated with increased risk of cardiovascular events. We investigated the association of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) with ankle-brachial index (ABI), a measure of peripheral arterial disease (PAD), in a biethnic cohort of adults without known coronary heart disease or stroke.
METHODS: Participants included 1102 blacks (mean age, 63 years; 74% women) and 1013 non-Hispanic whites (mean age, 58 years; 59% women) belonging to sibships ascertained on the basis of hypertension. We measured plasma concentrations of sICAM-1 and sVCAM-1 using high-sensitivity immunoassays and ABI using a standard protocol; PAD was defined as ABI <0.9. We used generalized estimating equations to assess whether sICAM-1 and sVCAM-1 were associated with ABI and PAD, independently of conventional risk factors.
RESULTS: After adjustment for conventional risk factors, blacks with sICAM-1 and sVCAM-1 concentrations in the highest quartiles had lower ABIs than those in the lowest quartiles (mean ABI 1.02 vs 0.98, P = 0.007, vs 1.02 vs 0.99, P = 0.003, respectively). In multivariable logistic regression analysis, sICAM-1 and sVCAM-1 concentrations in the highest quartiles were each associated with a higher odds ratio of having PAD, compared with the lowest quartiles: odds ratio (95% CI): 5.2 (1.8-15.2) and 2.2 (1.0-4.8), respectively. In contrast, in non-Hispanic whites, sICAM-1 and sVCAM-1 concentrations were not associated with ABI or PAD.
CONCLUSIONS: Higher sICAM-1 and sVCAM-1 concentrations were independently associated with lower ABI and PAD in blacks, but not in non-Hispanic whites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787016      PMCID: PMC2752683          DOI: 10.1373/clinchem.2008.107003

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  34 in total

1.  Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men.

Authors:  Aruna D Pradhan; Nader Rifai; Paul M Ridker
Journal:  Circulation       Date:  2002-08-13       Impact factor: 29.690

Review 2.  Prediction of cardiovascular risk using soluble cell adhesion molecules.

Authors:  N T Mulvihill; J B Foley; P Crean; M Walsh
Journal:  Eur Heart J       Date:  2002-10       Impact factor: 29.983

3.  Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.

Authors:  K Peter; P Nawroth; C Conradt; T Nordt; T Weiss; M Boehme; A Wunsch; J Allenberg; W Kübler; C Bode
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-03       Impact factor: 8.311

4.  Circulating cell adhesion molecules and death in patients with coronary artery disease.

Authors:  S Blankenberg; H J Rupprecht; C Bickel; D Peetz; G Hafner; L Tiret; J Meyer
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.

Authors:  S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

6.  Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

Authors:  P M Ridker; C H Hennekens; B Roitman-Johnson; M J Stampfer; J Allen
Journal:  Lancet       Date:  1998-01-10       Impact factor: 79.321

7.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content.

Authors:  K D O'Brien; T O McDonald; A Chait; M D Allen; C E Alpers
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

8.  Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta.

Authors:  K Nakai; C Itoh; K Kawazoe; Y Miura; H Sotoyanagi; K Hotta; T Itoh; J Kamata; K Hiramori
Journal:  Coron Artery Dis       Date:  1995-06       Impact factor: 1.439

Review 9.  Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

Authors:  R S Rosenson; C C Tangney
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

Review 10.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

View more
  5 in total

1.  Elevated Levels of Adhesion Proteins Are Associated With Low Ankle-Brachial Index.

Authors:  Cecilia Berardi; Christine L Wassel; Paul A Decker; Nicholas B Larson; Phillip S Kirsch; Mariza de Andrade; Michael Y Tsai; James S Pankow; Michele M Sale; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Mary M McDermott; Michael H Criqui; Michael A Allison; Suzette J Bielinski
Journal:  Angiology       Date:  2016-07-20       Impact factor: 3.619

2.  Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule.

Authors:  Anand Rohatgi; Andrew W Owens; Amit Khera; Colby R Ayers; Kamakki Banks; Sandeep R Das; Jarett D Berry; Darren K McGuire; James A de Lemos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10       Impact factor: 8.311

3.  Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease.

Authors:  Zi Ye; Zeenat Ali; George G Klee; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2013-01-11       Impact factor: 2.689

Review 4.  Novel markers of peripheral arterial disease.

Authors:  Farhan J Khawaja; Iftikhar J Kullo
Journal:  Vasc Med       Date:  2009-11       Impact factor: 3.239

5.  Association of Circulating Hepatocyte Growth Factor and Risk of Incident Peripheral Artery Disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Parveen K Garg; Petra Buzkova; Christina L Wassell; Matthew Allison; Michael Criqui; Nicholas B Larson; Suzette J Bielinski
Journal:  Angiology       Date:  2020-03-23       Impact factor: 3.619

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.